Access to a Diverse Array of Bridged Benzo[1,5]oxazocine and Benzo[1,4]diazepine Structures.


Journal

Organic letters
ISSN: 1523-7052
Titre abrégé: Org Lett
Pays: United States
ID NLM: 100890393

Informations de publication

Date de publication:
08 Dec 2023
Historique:
medline: 24 11 2023
pubmed: 24 11 2023
entrez: 23 11 2023
Statut: ppublish

Résumé

The preparation of bridged benzo[1,5]oxazocines and benzo[1,4]diazepines is demonstrated from simple aniline and aldehyde starting materials. A one-pot condensation/6π electrocyclization is followed by an intramolecular trapping of the 2,3-dihydroquinoline intermediate by nitrogen or oxygen nucleophiles to give bridged seven- and eight-membered products. Using 3-hydroxypyridinecarboxaldehydes results in a stable zwitterionic structure that can undergo a diastereoselective reduction under hydrogenative conditions. A similar cyclization/hydrogenation pathway with excellent diastereoselectivity is also demonstrated from 2-pyridyl-substituted 1,2,3,4-tetrahydroquinolines.

Identifiants

pubmed: 37996078
doi: 10.1021/acs.orglett.3c03392
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8585-8589

Auteurs

Grant J Sherborne (GJ)

Medicinal Chemistry Oncology R&D, Research and Early Development, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.

Coura Diène (C)

Medicinal Chemistry Oncology R&D, Research and Early Development, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.

Paul Kemmitt (P)

Medicinal Chemistry Oncology R&D, Research and Early Development, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.

Andrew D Smith (AD)

EaStCHEM School of Chemistry, University of St Andrews, St Andrews, Fife KY16 9ST, U.K.

Classifications MeSH